skip to content
Biologic and systemic agents in dermatology Preview this item
ClosePreview this item
Checking...

Biologic and systemic agents in dermatology

Author: Paul S Yamauchi
Publisher: Cham, Switzerland : Springer, [2018] ©2018
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:

Written by leading experts in the field and designed for dermatologists and residents, this book includes evidence-based medicine that underscores the clinical data, as well as practical tips on how  Read more...

Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Biologic and systemic agents in dermatology.
Cham, Switzerland : Springer, [2018]
(OCoLC)994728251
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Paul S Yamauchi
ISBN: 9783319668840 3319668846
OCLC Number: 1018307598
Description: 1 online resource
Contents:  History of Therapies in Dermatology.  Past to Present --
 Validated scoring systems --
 Interpreting Clinical Trial Data --
Compliance and Persistency --
 Quality of Life in the Dermatology Practice --
Medical Legal Issues with Biologic Agents in the Treatment of Psoriasis --
Patient and Physician Perspectives on Traditional  Systemic and Biologic Therapies for Psoriasis --
Outcomes of Comorbidities with Biologic and Systemic Agents   --
Pharmacovigilance --
Pharmacoeconomics of Biologic Therapy in Dermatology --
Immunogenicity of Biologic Agents in Psoriasis   --
Manufacturing of Biologics --
 Tumor Necrosis Factor Inhibition --
Dual Inhibition of IL-12/IL- 23 and Selective Inhibition of IL-23 in Psoriasis.- Interleukin-17 Inhibition for the Treatment  of Inflammatory Skin Disease --
Systemic Therapies in Psoriasis --
Nail, Scalp, and Palmoplantar Psoriasis --
 Current and Emerging Treatments for Psoriatic Arthritis --
JAK Kinase Inhibitors in Dermatology --
   Fumaric Acid Esters in Dermatology --
Phosphodiesterase Inhibitors for the Treatment of Inflammatory Skin Conditions --
Oral Retinoids in Dermatology --
 Combination Therapy with Biologics and Other Systemic Treatments in Psoriasis --
Transitioning Biologic and Systemic Therapies in Psoriatic Patients --
Practical Considerations and Complex Cases in Psoriasis --
Biosimilars in Dermatology --
Biological Agents in Pediatric Dermatology --
Oral systemic Agents in Pediatric Dermatology --
Utilization of Biologic and Systemic Agents in the Elderly --
 Miscellaneous Uses of Biologic and Systemic Agents in Other Dermatologic Conditions --
Biologics for the Treatment of Atopic Dermatitis --
Oral Agents for Atopic Dermatitis: Current and in Development --
 Cutaneous T-cell lymphoma --
 Anti-CD20 Agents and Potential Novel Biologics in Pemphigus Vulgaris and Other Autoimmune Blistering Diseases --
Oral Systemic Agents for Immunobullous Disorders --
Biologic and Systemic Agents in Hidradenitis Suppurativa --
Systemic and Biologic Agents for Lupus Erythematosus --
Anti-IgE Therapy in Dermatology --
Role of Intravenous Immunoglobulin in Dermatologic Disorders --
 Systemic Antifungals --
Systemic Antivirals in Dermatology   --
Antihelmintics in Dermatology --
 Systemic Therapies for Scarring and Non-scarring alopecia --
 Dapsone in Dermatology --
Systemic Non-Antibiotic Therapy in acne and rosacea --
Oral Antibiotics in Dermatology: A Practical Overview with Clinically Relevant Correlations and Management Suggestions --
Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma --
Update in Immunotherapies for Melanoma --
 Patient advocacy organizations.       .
Responsibility: Paul S. Yamauchi, editor.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/1018307598> # Biologic and systemic agents in dermatology
    a schema:Book, schema:CreativeWork, schema:MediaObject ;
    library:oclcnum "1018307598" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/sz> ;
    schema:about <http://dewey.info/class/616.5/e23/> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/4711456155#Topic/dermatologic_agents> ; # Dermatologic agents
    schema:about <http://experiment.worldcat.org/entity/work/data/4711456155#Topic/skin_diseases> ; # Skin--Diseases
    schema:about <http://experiment.worldcat.org/entity/work/data/4711456155#Topic/medical_evidence_based_medicine> ; # MEDICAL--Evidence-Based Medicine
    schema:about <http://experiment.worldcat.org/entity/work/data/4711456155#Topic/health_&_fitness_diseases_general> ; # HEALTH & FITNESS--Diseases--General
    schema:about <http://experiment.worldcat.org/entity/work/data/4711456155#Topic/medical_diseases> ; # MEDICAL--Diseases
    schema:about <http://experiment.worldcat.org/entity/work/data/4711456155#Topic/medical_internal_medicine> ; # MEDICAL--Internal Medicine
    schema:about <http://experiment.worldcat.org/entity/work/data/4711456155#Topic/medical_clinical_medicine> ; # MEDICAL--Clinical Medicine
    schema:about <http://experiment.worldcat.org/entity/work/data/4711456155#Topic/dermatology> ; # Dermatology
    schema:bookFormat schema:EBook ;
    schema:copyrightYear "2018" ;
    schema:datePublished "2018" ;
    schema:description " History of Therapies in Dermatology.  Past to Present --  Validated scoring systems --  Interpreting Clinical Trial Data -- Compliance and Persistency --  Quality of Life in the Dermatology Practice -- Medical Legal Issues with Biologic Agents in the Treatment of Psoriasis -- Patient and Physician Perspectives on Traditional  Systemic and Biologic Therapies for Psoriasis -- Outcomes of Comorbidities with Biologic and Systemic Agents   -- Pharmacovigilance -- Pharmacoeconomics of Biologic Therapy in Dermatology -- Immunogenicity of Biologic Agents in Psoriasis   -- Manufacturing of Biologics --  Tumor Necrosis Factor Inhibition -- Dual Inhibition of IL-12/IL- 23 and Selective Inhibition of IL-23 in Psoriasis.- Interleukin-17 Inhibition for the Treatment  of Inflammatory Skin Disease -- Systemic Therapies in Psoriasis -- Nail, Scalp, and Palmoplantar Psoriasis --  Current and Emerging Treatments for Psoriatic Arthritis -- JAK Kinase Inhibitors in Dermatology --    Fumaric Acid Esters in Dermatology -- Phosphodiesterase Inhibitors for the Treatment of Inflammatory Skin Conditions -- Oral Retinoids in Dermatology --  Combination Therapy with Biologics and Other Systemic Treatments in Psoriasis -- Transitioning Biologic and Systemic Therapies in Psoriatic Patients -- Practical Considerations and Complex Cases in Psoriasis -- Biosimilars in Dermatology -- Biological Agents in Pediatric Dermatology -- Oral systemic Agents in Pediatric Dermatology -- Utilization of Biologic and Systemic Agents in the Elderly --  Miscellaneous Uses of Biologic and Systemic Agents in Other Dermatologic Conditions -- Biologics for the Treatment of Atopic Dermatitis -- Oral Agents for Atopic Dermatitis: Current and in Development --  Cutaneous T-cell lymphoma --  Anti-CD20 Agents and Potential Novel Biologics in Pemphigus Vulgaris and Other Autoimmune Blistering Diseases -- Oral Systemic Agents for Immunobullous Disorders -- Biologic and Systemic Agents in Hidradenitis Suppurativa -- Systemic and Biologic Agents for Lupus Erythematosus -- Anti-IgE Therapy in Dermatology -- Role of Intravenous Immunoglobulin in Dermatologic Disorders --  Systemic Antifungals -- Systemic Antivirals in Dermatology   -- Antihelmintics in Dermatology --  Systemic Therapies for Scarring and Non-scarring alopecia --  Dapsone in Dermatology -- Systemic Non-Antibiotic Therapy in acne and rosacea -- Oral Antibiotics in Dermatology: A Practical Overview with Clinically Relevant Correlations and Management Suggestions -- Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma -- Update in Immunotherapies for Melanoma --  Patient advocacy organizations.       ."@en ;
    schema:editor <http://experiment.worldcat.org/entity/work/data/4711456155#Person/yamauchi_paul_s> ; # Paul S. Yamauchi
    schema:exampleOfWork <http://worldcat.org/entity/work/id/4711456155> ;
    schema:genre "Electronic books"@en ;
    schema:inLanguage "en" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/994728251> ;
    schema:name "Biologic and systemic agents in dermatology"@en ;
    schema:productID "1018307598" ;
    schema:url <http://public.eblib.com/choice/publicfullrecord.aspx?p=5214710> ;
    schema:url <http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1671820> ;
    schema:url <http://dx.doi.org/10.1007/978-3-319-66884-0> ;
    schema:url <https://0-link-springer-com.pugwash.lib.warwick.ac.uk/10.1007/978-3-319-66884-0> ;
    schema:url <http://link.springer.com/10.1007/978-3-319-66884-0> ;
    schema:url <https://link.springer.com/10.1007/978-3-319-66884-0> ;
    schema:url <https://0-link-springer-com.pugwash.lib.warwick.ac.uk/book/10.1007/978-3-319-66884-0> ;
    schema:workExample <http://dx.doi.org/10.1007/978-3-319-66884-0> ;
    schema:workExample <http://worldcat.org/isbn/9783319668840> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/1018307598> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/4711456155#Person/yamauchi_paul_s> # Paul S. Yamauchi
    a schema:Person ;
    schema:familyName "Yamauchi" ;
    schema:givenName "Paul S." ;
    schema:name "Paul S. Yamauchi" ;
    .

<http://experiment.worldcat.org/entity/work/data/4711456155#Topic/dermatologic_agents> # Dermatologic agents
    a schema:Intangible ;
    schema:name "Dermatologic agents"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4711456155#Topic/health_&_fitness_diseases_general> # HEALTH & FITNESS--Diseases--General
    a schema:Intangible ;
    schema:name "HEALTH & FITNESS--Diseases--General"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4711456155#Topic/medical_clinical_medicine> # MEDICAL--Clinical Medicine
    a schema:Intangible ;
    schema:name "MEDICAL--Clinical Medicine"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4711456155#Topic/medical_diseases> # MEDICAL--Diseases
    a schema:Intangible ;
    schema:name "MEDICAL--Diseases"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4711456155#Topic/medical_evidence_based_medicine> # MEDICAL--Evidence-Based Medicine
    a schema:Intangible ;
    schema:name "MEDICAL--Evidence-Based Medicine"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4711456155#Topic/medical_internal_medicine> # MEDICAL--Internal Medicine
    a schema:Intangible ;
    schema:name "MEDICAL--Internal Medicine"@en ;
    .

<http://worldcat.org/isbn/9783319668840>
    a schema:ProductModel ;
    schema:isbn "3319668846" ;
    schema:isbn "9783319668840" ;
    .

<http://www.worldcat.org/oclc/994728251>
    a schema:CreativeWork ;
    rdfs:label "Biologic and systemic agents in dermatology." ;
    schema:description "Print version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/1018307598> ; # Biologic and systemic agents in dermatology
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.